Hyoscyamine Sulfate Sl
NDC Package 67296-1280-3

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Hyoscyamine Sulfate Sl is hyoscyamine sulfate is indicated whenever antispasmodic or anticholinergic therapy is desired. Marketed by Redpharm Drug, Inc., this product is identified by NDC 67296-1280.

Identification & Billing

NDC Package Code
67296-1280-3
Package Description
30 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
67296128003
RxNorm Crosswalk
RxCUI: 1047905 - hyoscyamine sulfate 0.125 MG Oral Tablet

Clinical Specifications

Proprietary Name
Hyoscyamine Sulfate Sl
Dosage Form
-
Usage Information
Hyoscyamine sulfate is indicated whenever antispasmodic or anticholinergic therapy is desired. The high degree of purity allows effective action at very low dosage, with a minimal incidence of unwanted side effects.

Regulatory & Marketing

Labeler Name
Redpharm Drug, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
09-04-2011
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67296-1280-3 identifies a specific commercial package of 30 tablet in 1 bottle of Hyoscyamine Sulfate Sl, labeled by Redpharm Drug, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Redpharm Drug, Inc. on September 04, 2011. The current certification is valid through December 31, 2021.

How is this Redpharm Drug, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296128003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67296-1280-3
11-Digit CMS (5-4-2)
67296-1280-03

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.